Aurobindo Pharma Limited has informed the Exchange regarding a press release dated November 30, 2023, titled "Eugia Pharma, a 100% subsidiary receives USFDA approval for Budesonide Inhalation Suspension".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated November 30, 2023, titled "Eugia Pharma, a 100% subsidiary receives USFDA approval for Budesonide Inhalation Suspension".